Back to VANGUARD GROUP INC VANGUARD GROUP INC

BCRXBCRX
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in BIOCRYST PHARMACEUTICALS INC

VANGUARD GROUP INC holds 22.3M shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $173.7M as of 2025-Q4. The position was increased (+2.2% shares). BCRX represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$173.7M

Current Shares

22.3M

Total Value Change

+$19.4M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
22.3M
+2.2%
$173.7M0.0%$7.80
31
2025-Q3
Increased
21.8M
+6.1%
$165.4M0.0%$7.59
32
2025-Q2
Decreased
20.5M
-5.2%
$184.1M0.0%$8.96
0
2025-Q1
Decreased
21.7M
-1.1%
$162.4M0.0%$7.50
0
2024-Q4
Increased
21.9M
+7.8%
$164.6M0.0%$7.52
33
2024-Q3
New
20.3M
-
$154.3M0.0%$7.60
42

Other major holders of BCRX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used